|
Volumn 26, Issue 2, 2002, Pages 209-217
|
Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence
|
Author keywords
Alcohol dependence; Alcoholism; Anticraving drug; Apomorphine; Dopamine agonist; Drug effect expectancy; Growth hormone; Lisuride; Relapse
|
Indexed keywords
APOMORPHINE;
DOPAMINE;
DOPAMINE 2 RECEPTOR STIMULATING AGENT;
GROWTH HORMONE;
LISURIDE;
PLACEBO;
ADULT;
ALCOHOL CONSUMPTION;
ALCOHOL WITHDRAWAL;
ALCOHOLISM;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOPAMINERGIC ACTIVITY;
DOUBLE BLIND PROCEDURE;
DRUG DEPENDENCE TREATMENT;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
GROUP THERAPY;
HUMAN;
HYPOTENSION;
MAJOR CLINICAL STUDY;
MALE;
NEUROENDOCRINE SYSTEM;
OUTPATIENT;
PATIENT COUNSELING;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
SURVIVAL;
TREATMENT OUTCOME;
VERTIGO;
ADULT;
ALCOHOLISM;
BEHAVIOR, ADDICTIVE;
CHI-SQUARE DISTRIBUTION;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LISURIDE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RECEPTORS, DOPAMINE D2;
RECURRENCE;
SURVIVAL ANALYSIS;
|
EID: 0036138013
PISSN: 02785846
EISSN: None
Source Type: Journal
DOI: 10.1016/S0278-5846(01)00214-7 Document Type: Article |
Times cited : (24)
|
References (49)
|